Choy Francis Y M, Zhang Weimin, Shi Hui-Ping, Zay Agnes, Campbell Tessa, Tang Nelson, Ferreira Patrick
Department of Biology, Centre for Biomedical Research, University of Victoria, Victoria, British Columbia, Canada.
Blood Cells Mol Dis. 2007 May-Jun;38(3):287-93. doi: 10.1016/j.bcmd.2006.11.003. Epub 2006 Dec 29.
Gaucher disease, the most prevalent lysosomal storage disease, results from an inherited deficiency in the enzyme glucocerebrosidase. Three clinical forms of Gaucher disease have been described: Type 1 non-neuronopathic, Type 2 acute neuronopathic, and Type 3 subacute neuronopathic. Although Gaucher disease is panethnic, its presentation reveals some ethnic-specific characteristics. The Type 1 form is most common among Caucasian patients. In contrast, the majority of Chinese Gaucher disease patients have early age of onset, severe hematological and skeletal complications, and often neurological involvement, resulting in early childhood death. In this report, we review 29 cases of Gaucher disease from 23 unrelated patients and 6 patients from 3 non-consanguineous families. Among these patients, 13 were diagnosed as Type 1, 10 as Type 2, and 6 as Type 3. A novel mutation, del 205-209ACCTT, was identified in the heterozygous form with mutation R353W (c.1174C>T) by DNA sequence analysis in 2 Type 1 patients who are sibs. Mutation R353W was also found in the heterozygous form in 3 other Type 1 patients, with mutation L444P in 2 sibs and a second unknown Gaucher allele in the third patient. The Gaucher genotypes of the remaining Type 1 patients were F37V/L444P, G46E/L444P, R48W/R120W, N188S/L444P, Y205C/L444P, N370S/L444P, and L444P/unknown. It was noted that mutation N370S in the patient was linked to the pv1.1(-)(1) haplotype present in Jewish patients. Among the Type 2 patients, L444P was present in the heterozygous form with mutation F213I, L385P, or the complex allele (RecNci) in 5 patients. The second most common mutation, F213I, was found in the heterozygous form in 6 patients with mutations N382K, L383R, or L444P. The other mutations found in the Type 2 patients were P122L, V375L, Y363C, M416V, and 383-400del. The genotypes of the 6 Type 3 patients identified were D409H/D409H, D409H/G202R, G46E/N188S, N188S/unknown, and L444P/L444P. While D409H has been reported as being associated with cardiovascular/ocular involvements in Gaucher disease, there have been no such complications in these patients. As noted, the majority of the Gaucher mutations we identified in the Chinese patients were either rare or absent in other populations. With the exception of N370S and R353W found only in the Type 1 form, the majority of these mutations are severe ones that result in poor prognosis and often Types 2 and 3 Gaucher disease.
戈谢病是最常见的溶酶体贮积病,由遗传性葡糖脑苷脂酶缺乏引起。已描述了戈谢病的三种临床类型:1型非神经病变型、2型急性神经病变型和3型亚急性神经病变型。尽管戈谢病在各民族中均有发生,但其表现呈现出一些种族特异性特征。1型在白种人患者中最为常见。相比之下,大多数中国戈谢病患者发病年龄早,有严重的血液学和骨骼并发症,且常伴有神经受累,导致儿童早期死亡。在本报告中,我们回顾了来自23例无亲缘关系患者和3个非近亲家庭的6例患者的29例戈谢病病例。在这些患者中,13例被诊断为1型,10例为2型,6例为3型。通过DNA序列分析,在2例为同胞的1型患者中发现了一种新的突变,即杂合形式的del 205 - 209ACCTT与突变R353W(c.1174C>T)。在另外3例1型患者中也发现了杂合形式的突变R353W,在2例同胞中发现了突变L444P,在第三例患者中发现了另一个未知的戈谢等位基因。其余1型患者的戈谢基因型为F37V/L444P、G46E/L444P、R48W/R120W、N188S/L444P、Y205C/L444P、N370S/L444P和L444P/未知。值得注意的是,该患者中的突变N370S与犹太患者中存在的pv1.1(-)(1)单倍型相关。在2型患者中,5例患者存在杂合形式的L444P与突变F213I、L385P或复合等位基因(RecNci)。第二常见的突变F213I在6例患者中以杂合形式出现,这些患者还伴有突变N382K、L383R或L444P。在2型患者中发现的其他突变有P122L、V375L、Y363C、M416V和383 - 400del。所鉴定的6例3型患者的基因型为D409H/D409H、D409H/G202R、G46E/N188S、N188S/未知和L444P/L444P。虽然D409H已被报道与戈谢病的心血管/眼部受累有关,但这些患者中并未出现此类并发症。如前所述,我们在中国患者中鉴定出的大多数戈谢突变在其他人群中要么罕见要么不存在。除了仅在1型中发现的N370S和R353W外,这些突变大多数是严重的,会导致预后不良,且常引发2型和3型戈谢病。